# CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM-NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK-FEMALE SITES-CORE FUNCTION ACTIVITIES

> **NIH NIH N01** · JOHNS HOPKINS UNIVERSITY · 2020 · $9,957

## Abstract

There is a demand for new methods of contraception that can provide effective protection
against unintended pregnancy as well as reduce the risk of venous thromboembolism
(VTE), particularly for obese women. The mission of the Contraceptive Clinical Trials
Network (CCTN) is to develop protocols and conduct clinical trials that will assist in
product development with the end goal to provide effective and safe contraception for
women.
The Eunice Kennedy Shriver National Institute of Child Health and Human Development
(NICHD) has a mission to develop safe and effective contraceptives for women,
including obese women and women who have medical conditions for which current
contraceptive products are contraindicated.

## Key facts

- **NIH application ID:** 10237716
- **Project number:** 75N94020D00017-0-759402000001-1
- **Recipient organization:** JOHNS HOPKINS UNIVERSITY
- **Principal Investigator:** ANNE BURKE, M.D., MPH
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $9,957
- **Award type:** —
- **Project period:** 2020-08-01 → 2021-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10237716

## Citation

> US National Institutes of Health, RePORTER application 10237716, CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM-NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK-FEMALE SITES-CORE FUNCTION ACTIVITIES (75N94020D00017-0-759402000001-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10237716. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*